Virpax Pharmaceuticals, Inc. (VRPX)
OTCMKTS · Delayed Price · Currency is USD
0.4000
+0.0390 (10.80%)
Jul 16, 2025, 3:52 PM EDT
Virpax Pharmaceuticals Market Cap
Virpax Pharmaceuticals has a market cap or net worth of $448.54 thousand as of July 16, 2025. Its market cap has decreased by -68.53% in one year.
Market Cap
448.54K
Enterprise Value
-1.06M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.40
Market Cap Chart
Since February 17, 2021, Virpax Pharmaceuticals's market cap has decreased from 32.29M to 448.54K, a decrease of -98.61%. That is a compound annual growth rate of -62.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2025 | 448.54K | -85.40% |
| Dec 31, 2024 | 3.07M | -18.06% |
| Dec 29, 2023 | 3.75M | -48.56% |
| Dec 30, 2022 | 7.29M | -81.86% |
| Dec 31, 2021 | 40.18M | 24.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.60B |
| Veradigm | 840.66M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 575.00M |
| Nika Pharmaceuticals | 554.26M |
| Glass House Brands | 416.87M |
| CytoDyn | 399.02M |
| Northwest Biotherapeutics | 384.78M |